Turn CMC Knowledge Into Controlled, Traceable Reports Faster with ValGenesis iCMC™
Summary
iCMC brings report generation into the governed CMC lifecycle by enabling teams to generate reports using product and process knowledge already captured within their projects. By reducing manual information gathering and report assembly, iCMC helps teams turn evolving product and process knowledge into controlled, traceable reports within a governed system that supports built-in versioning, approvals, and audit trails.Key Takeaways
- Reduce manual report assembly. Generate reports without repeatedly gathering, transferring, and consolidating data.
- Keep reporting connected to CMC development. Bring structured product and process knowledge directly into the reporting environment.
- Support structured review and approval. Configurable approval workflows and electronic signatures help teams manage report review.
- Standardize with flexibility. Configurable templates support consistent reporting across products, programs, and sites while accommodating project-specific requirements.
Who is this for
- CMC and process development teams responsible for translating development knowledge into formal reports and packages.
- MS&T and quality teams seeking greater consistency, efficiency, and traceability across CMC reporting.
- CMC leaders looking to standardize reporting and reduce manual effort across programs and sites.
Relevant Entities to this Post
ICH — ICH Q10: Pharmaceutical Quality System
Chemistry, manufacturing and controls (CMC) teams spend years building product and process knowledge. But when it is time to turn that knowledge into a formal report or CMC package, too much of the work can still depend on manually assembling information from spreadsheets, documents, risk files, and other disconnected sources.
The challenge becomes greater as development progresses. Process understanding evolves, risk assessments change, control strategies mature, and new data becomes available. Meanwhile, teams must locate relevant information, consolidate findings, and communicate the scientific rationale behind development decisions. When information is distributed across multiple files and systems, preparing reports can become a time-consuming exercise in reconstructing knowledge that has already been documented elsewhere. This creates unnecessary effort at exactly the point where teams need confidence in the data, consistency, and traceability.
ValGenesis iCMC™ brings report generation into the governed CMC lifecycle, helping teams transform structured development and process knowledge into reports with less manual effort. Instead of treating reporting as a separate documentation exercise, iCMC brings reporting closer to the governed CMC knowledge it is intended to communicate.
The Hidden Cost of Manual CMC Reporting
Creating a CMC report is rarely as simple as opening a document and starting to write. Authors may need to locate the latest process information, transfer tables from other systems, reconcile different versions of risk assessments, confirm previous decisions, and reconstruct the rationale behind them.
Every manual handoff can introduce friction, as copying information creates opportunities for inconsistency, and separate files make information retrieval and consolidation more difficult. Narrative edits may lack sufficient traceability. And when reviewers question a particular conclusion or data point, teams may need to work backward through multiple files to understand where the information originated.
The problem is not that CMC teams lack information. They often have an enormous amount of it. The problem is converting that information into a controlled, coherent report without losing its context along the way.
Bring Governed CMC Knowledge Into Reporting
iCMC provides a configurable reporting capability that allows teams to extract relevant project information into structured reports on demand. Using the report builder, teams can configure reports for different purposes, with custom tables and formatting populated using existing project information. A Word-style editor provides flexibility for scientific narrative, while an intuitive content index helps teams structure and navigate more complex reports. Both tools are built into iCMC, eliminating the need for manual data retrieval, consolidation, and handoffs.
This creates an important shift in the reporting workflow. Product and process development activities, including quality risk management and control strategy development, are central to the lifecycle approaches described in ICH Q8(R2), Q9(R1), and Q10 (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use [ICH], 2008, 2009, 2023).
iCMC helps teams capture and structure knowledge across these activities through tools such as process mapping, risk assessments, FMEA, and control strategy development. Rather than repeatedly locating, consolidating, and contextualizing that knowledge when a report is needed, teams can bring relevant project information forward into the reporting environment on demand.
Reports capture project information at the time of generation, providing a structured starting point for further scientific interpretation and documentation. As underlying project information evolves, reports can be regenerated or updated as appropriate to reflect the latest available knowledge. That means less time spent finding, transferring, and reformatting information—and more focus on interpreting the science and communicating the decisions behind it.
Keep Review and Approval Controlled
CMC knowledge does not stand still, and neither do the reports that communicate it. As products move through development, reports may undergo numerous rounds of authoring, technical review, quality review, and approval. Managing those iterations through shared drives, local files, and email attachments can quickly create uncertainty around which document represents the latest controlled version.
iCMC supports this workflow through configurable review and approval capabilities. After a report is created using the report builder tool, it remains in draft status, where it is editable until pushed into the review and approval cycle. Configurable approval workflows and electronic signatures support formal review activities within the platform. Reviewers can accept or reject reports as part of the approval process, while users can replicate reports when additional working copies are needed.
The value extends beyond document administration. By supporting report preparation, review, and approval within the same environment, iCMC helps reduce reliance on disconnected document exchanges and provides a more structured approach to CMC reporting.
Bringing Traceability to the Scientific Narrative
Some of the most important content in a CMC report cannot be reduced to a data field or table. Teams still need to explain why a process parameter matters, how a risk was evaluated, what development data demonstrated, or how the evidence supports a particular control strategy. These scientific narratives require interpretation and judgment and may evolve through collaboration and review, making the history behind those changes important.
In iCMC, the information supporting those conclusions does not need to be assembled from scratch every time a report is prepared. For example, information documented during a routine risk assessment can be used to support reporting on identified process risks, their potential impact on product quality, and the rationale behind connected control measures.
Scientists can then supplement that structured information with the necessary interpretation, conclusions, and supporting context using the report editor, a Word-style tool built directly into the system.
This approach helps bridge the gap between documenting CMC development activities and communicating their outcomes to internal teams and regulatory agencies. Rather than rebuilding the supporting information each time, teams can focus their efforts on evaluating the science and presenting a clear, coherent account of product and process understanding.
Standardize Reporting Without Sacrificing Flexibility
Global CMC organizations face a balancing act: reports need enough standardization to promote consistency but enough flexibility to accommodate different products, development stages, and scientific requirements.
iCMC addresses that balance through configurable report templates that can establish repeatable structures, while the broader templates manager supports organizational standards for system use. Organizations can define consistent reporting formats while allowing teams to adapt content to the needs of individual projects. At the same time, flexible editing and custom tables provide additional options for presenting information, including reference lists, materials and equipment lists, and other supporting content.
As organizations scale across programs and sites, this combination can help reduce repeated report-building work while improving consistency in how CMC knowledge is communicated. Standardization also supports more efficient review by providing a familiar structure for evaluating information across different projects and development programs.
Make Reporting Part of the CMC Lifecycle
The real opportunity is bigger than generating a report faster. CMC organizations invest heavily in building process understanding, evaluating risk, developing control strategies, and capturing knowledge throughout development. These activities contribute to the lifecycle approach to pharmaceutical development and quality management described in ICH Q8(R2), Q9(R1), and Q10 (ICH, 2008, 2009, 2023). That information and scientific rationale should remain accessible when teams reach the reporting stage.
By incorporating structured project information into configurable reports, all within a single governed system, iCMC helps transform reporting from a manual document-assembly exercise into a more connected and controlled extension of the CMC lifecycle.
Combined with flexible narrative editing, standardized templates, and configurable review and approval workflows, this approach helps reduce manual report assembly while supporting more consistent communication of CMC information. Spend less time reconstructing CMC knowledge into documents—and more time interpreting the science and communicating the decisions behind it.
Citations
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (2008). https://database.ich.org/sites/default/files/Q10_Guideline.pdf
ICH Q10: Pharmaceutical quality system. Accessed Date: 27 October 2026.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (2009). https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf
ICH Q8(R2): Pharmaceutical development.. Accessed Date: 27 October 2026.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (2023). https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Guideline_Step4_2025_0115_0.pdf
ICH Q9(R1): Quality risk management. Accessed Date: 27 October 2026.
The opinions, information and conclusions contained within this blog should not be construed as conclusive fact, ValGenesis offering advice, nor as an indication of future results.